Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CareView Communications (CRVW) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for CareView Communications (CRVW) over the last 17 years, with Q3 2025 value amounting to $1.7 million.

  • CareView Communications' Cash & Equivalents rose 2362.85% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 2362.85%. This contributed to the annual value of $759266.0 for FY2024, which is 3373.9% down from last year.
  • CareView Communications' Cash & Equivalents amounted to $1.7 million in Q3 2025, which was up 2362.85% from $1.8 million recorded in Q2 2025.
  • In the past 5 years, CareView Communications' Cash & Equivalents registered a high of $1.8 million during Q2 2025, and its lowest value of $271067.0 during Q3 2021.
  • Moreover, its 5-year median value for Cash & Equivalents was $707345.0 (2023), whereas its average is $863456.3.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first plummeted by 3968.76% in 2021, then soared by 17271.86% in 2023.
  • Over the past 5 years, CareView Communications' Cash & Equivalents (Quarter) stood at $659228.0 in 2021, then plummeted by 36.26% to $420166.0 in 2022, then soared by 172.72% to $1.1 million in 2023, then crashed by 33.74% to $759266.0 in 2024, then skyrocketed by 128.02% to $1.7 million in 2025.
  • Its Cash & Equivalents was $1.7 million in Q3 2025, compared to $1.8 million in Q2 2025 and $1.0 million in Q1 2025.